FDA Drug Recall: Phenylephrine IV Bags Recalled for Manufacturing Deviations
Denver Solutions recalls 1,212 units of Phenylephrine HCl IV bags nationwide due to Current Good Manufacturing Practice (CGMP) deviations. The voluntary recall affects products distributed across the U.S. including government facilities.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II drug recall for manufacturing practice deviations in an intravenous medication meets the rubric criterion of a 'risk-of-harm product where injury has not yet been reported,' warranting a High severity score.
Plain-English summary
Phenylephrine HCl 40 mg (160 mcg/mL) compounded in 0.9% Sodium Chloride 250 mL IV bags manufactured by Denver Solutions, LLC (Leiters Health) are being recalled. The affected product has NDC 71449-150-82 with Lot #2231017, expiring March 12, 2023. A total of 1,212 units were distributed.
The recall was initiated due to Current Good Manufacturing Practice (CGMP) deviations. Denver Solutions voluntarily initiated the recall on February 21, 2023, and the FDA classified it as a Class II recall.
The affected product was distributed nationwide throughout the United States, including to Department of Veterans Affairs facilities and other government healthcare facilities. Healthcare providers that received this product should immediately quarantine and return any remaining units.
Any facility or provider with this product should not use it and should contact the manufacturer or their pharmaceutical supplier for return or destruction procedures. This recall was officially terminated on January 11, 2024.
The recalled product
- Product
- Phenylephrine HCl 40 mg (160 mcg/mL) added to 0.9% Sodium Chloride 250 mL IV Bag, Leiter Compounding Health 13796 Compark Blvd Englewood CO 80112, NDC 71449-150-82
- Manufacturer
- Denver Solutions, LLC DBA Leiters Health
- Hazard
- Affected units
- 1,212
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 2231017
- Exp. Date 3/12/2023
Distribution
Part of a larger recall action
This product is one of 4 recalled by Denver Solutions, LLC DBA Leiters Health under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 4 products in this recall →Related recalls
Same manufacturer · Denver Solutions, LLC DBA Leiters Health
See all →- SevereDexmedetomidine HCl Syringes Recalled for Potential Sterility Issue
FDA (Drugs) · 2025-04-30
- SevereKetamine HCl Syringes Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2025-04-30
- SeverePHENYLephrine HCl Injection Syringes Recalled for Lack of Sterility
FDA (Drugs) · 2025-04-30
- HighGlycopyrrolate 1mg/5mL Syringes Recalled for Sterility Risk
FDA (Drugs) · 2025-04-30
- SevereRocuronium Bromide Syringes Recalled Due to Sterility Assurance Risk
FDA (Drugs) · 2025-04-30
Same hazard · cgmp deviation
See all →- SevereBaxter Recalls Daptomycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- HighBaxter Recalls MYXREDLIN Insulin Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Vancomycin Injection Due to CGMP Deviations
FDA (Drugs) · 2026-09-09
- HighBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09